Form 8-K

8-K — Park Dental Partners, Inc.

Accession: 0001104659-26-094967

Filed: 2026-08-12

Period: 2026-08-12

CIK: 0002069604

SIC: 8090 (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — park-20260812x8k.htm (Primary)

EX-99.1 (park-20260812xex99d1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: park-20260812x8k.htm · Sequence: 1

Park Dental Partners, Inc._August 12, 2026

0002069604false00020696042026-08-122026-08-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 12, 2026

Park Dental Partners, Inc.

(Exact name of registrant as specified in its charter)

Minnesota

001-42967

93-2020683

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification Number)

2200 County Road C West, Suite 2210

Roseville, Minnesota 55113

(Address of Principal Executive Offices) (Zip Code)

(651) 633-0500

(Registrant's Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

PARK

The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 2.02 Results of Operations and Financial Condition.

On August 12, 2026, Park Dental Partners, Inc. (the “Company”) issued a press release on the Company’s website announcing its second quarter 2026 financial results for the reporting period ended June 30, 2026. On August 13, 2026, the Company will host its quarterly earnings conference call, which will be accessible to the public.

A copy of the Company’s press release is furnished as Exhibit 99.1 and is attached to this Current Report on Form 8-K. The information in this Item 2.02 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filings under the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Exhibit

99.1

Press Release dated August 12, 2026 of Park Dental Partners, Inc.

104

Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 12, 2026

PARK DENTAL PARTNERS, INC.

By:

/s/ Christopher J. Bernander

Name:

Christopher J. Bernander

Title:

Chief Financial Officer

EX-99.1

Filename: park-20260812xex99d1.htm · Sequence: 2

Exhibit 99.1

Park Dental Partners Announces Second Quarter 2026 Results

FOR IMMEDIATE RELEASE

Minneapolis, Minn. — August 12, 2026 — Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its second quarter financial results for 2026. Summary financial results are listed below and in the accompanying supplemental financial tables.

(Unaudited, in millions, except per share data,

Three Months Ended June 30,

Six Months Ended June 30,

and Doctor counts)

2026

2025

Change

2026

2025

Change

Revenue

66.2

63.0

5.1

128.9

122.0

5.6

Gross Margin

9.5

11.9

(20.1)

15.9

21.8

(27.0)

Gross Margin percentage

14.4

18.9

(450)

bps

12.3

17.8

(550)

bps

Net Income

1.3

2.6

(47.5)

1.0

4.1

(76.8)

Diluted EPS

0.22

1.45

(1.23)

0.16

2.33

(2.17)

Adjusted Gross Margin(a)

14.7

14.1

4.2

26.9

26.0

3.4

Adjusted Gross Margin Percentage(a)

22.2

22.4

(20)

bps

20.9

21.3

(40)

bps

Adjusted EBITDA(b)

7.4

7.6

(1.7)

12.2

13.0

(6.5)

Adjusted EBITDA margin(b)

11.2

12.0

(80)

bps

9.4

10.7

(130)

bps

Adjusted Diluted EPS(c)

0.66

1.88

(1.22)

1.11

3.02

(1.91)

Same Practice Revenue Growth

2.3

5.8

(350)

bps

3.2

3.6

(40)

bps

Practicing Affiliated Doctors

219

203

7.9

(a)

See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below

(b)

See Non GAAP Reconciliation of Net Income to Adjusted EBITDA below

(c)

See Non GAAP Reconciliation of Earnings Per Share to Adjusted Earnings Per Share below

Executive Commentary – Pete Swenson, Chief Executive Officer and Chair of the Board of Directors

“We delivered another quarter of revenue growth, supported by positive same-practice performance, strong patient retention, and continued expansion of our affiliated doctor base. Our underlying operations are performing well and generated strong operating cash flows during the quarter.

Patient demand across both general and specialty services remains resilient, and we continue investing in recruiting, staffing, clinical capacity, and strategic growth initiatives designed to support long-term value creation. Our balance sheet remains strong, providing flexibility to pursue disciplined acquisitions, support de novo expansion opportunities, and continue investing in our affiliated practices.”

Financial Results

● Revenue increased 5.1% to $66.2 million for the second quarter of 2026, compared to $63.0 million in the prior-year period. For the first six months of 2026, revenue increased 5.6% to $128.9 million, compared to $122.0 million in the prior-year period. The increases were primarily driven by acquisitions completed since the comparable prior-year periods, favorable reimbursement trends, and growth in clinical hours. Revenue from acquisitions in the past 12 months contributed approximately $1.3 million in the quarter and $2.0 million year-to-date.

● Gross profit was $9.5 million for the second quarter of 2026, compared to $11.9 million in the prior-year period. For the first six months of 2026, gross profit was $15.9 million, compared to $21.8 million in the prior-year period. Gross profit was impacted by higher salaries and benefits expense, including doctor share-based compensation associated with the Company's public company transition.

● Net income was $1.3 million, or $0.22 per diluted share, for the second quarter of 2026, compared to $2.6 million, or $1.45 per diluted share, in the second quarter of 2025. For the first six months of 2026, net income was $1.0 million, or $0.16 per diluted share, compared to $4.1 million, or $2.33 per diluted share, in the prior-year period.

● Adjusted EBITDA was $7.4 million for the second quarter of 2026, compared to $7.6 million in the prior-year period. For the first six months of 2026, Adjusted EBITDA was $12.2 million, compared to $13.0 million in the prior-year period.

● Adjusted diluted earnings per share was $0.66 for the second quarter of 2026, compared to $1.88 in the prior-year period. For the first six months of 2026, adjusted diluted earnings per share was $1.11, compared to $3.02 in the prior-year period.

Affiliated Practice Updates

● As of June 30, 2026, we supported 87 affiliated practices and 219 affiliated doctors.

● Second quarter patient retention rate was 90.3%.

● Patient visits increased to 185,569 across our affiliated dental practices.

● During the second quarter our affiliated dental practices completed one general practice acquisition in Rochester, Minnesota, as previously announced on June 4, 2026. The acquired practices’ impact on revenues and net earnings was not material for the quarter.

● Entered into definitive agreement to acquire Village Family DSO, as announced on August 10, 2026. The Village Family DSO is currently affiliated with Village Family Dental practices, a multi-specialty dental group based in Fayetteville, North Carolina. If completed, the transaction would mark our expansion into a fourth state, supporting an additional 48 doctors. The transaction is expected to close later this year.

Balance Sheet, Liquidity, and Cash Flow

● Cash and cash equivalents were $24.4 million as of June 30, 2026.

● Total debt outstanding was approximately $11.0 million as of June 30, 2026, and our $15 million line of credit was undrawn at quarter end.

● Total shares outstanding were 4.7 million shares as of the end of the quarter.

● We generated $9.7 million in operating cash flow in the first half of 2026, an increase of $0.5 million compared to the prior year.

● Year-to-date capital investments were $4.8 million.

Full-Year 2026 Outlook

Based on our performance during the first half of 2026 and our current expectations for the remainder of the year, we are updating our full-year 2026 outlook.

Our updated outlook does not contemplate the recently announced acquisition of Village Family Dental DSO, which remains subject to customary closing conditions and is expected to close later this year. Consistent with our historical approach, only completed acquisitions are incorporated into our outlook. Following the close of the transaction, we expect to evaluate its anticipated financial impact and provide an updated outlook at an appropriate time.

Our revised outlook reflects continued confidence in the underlying performance of our affiliated practices, including patient demand, same-practice revenue growth, provider recruitment, and operational execution.

Year Ending

Year Ended

Percent

December 31, 2026

December 31, 2025

Change

($ in millions)

(Outlook)

(Actual)

(At Midpoint)

Revenue

$256.0 – $260.0

244.5

5.5

Adjusted EBITDA

$21.0 – $23.0

22.0

—

Adjusted EBITDA margin

8.2% - 8.8%

9.0

Our outlook includes 3.5% to 5.0% organic revenue growth and approximately $2 million recurring public company costs, driven by increased legal, audit, and investor relation fees we expect to incur in 2026. The outlook assumes continued patient demand across general and specialty services, stable reimbursement trends across commercial and government payors, ongoing recruitment and retention initiatives, and contributions from recently acquired and affiliated practices and de novos. We continue to monitor patient demand, industry and professional staffing trends that could impact our outlook.

Conference Call

As announced on July 20, 2026, the Company will host a conference call to discuss these results tomorrow morning, Thursday, August 13, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

A live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call. A replay of the webcast will be available on the website for a limited time following the call.

About Park Dental Partners, Inc.

Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. The Company has 219 affiliated doctors across 87 practice locations in three states. The Company’s clinical support team consists of over 1,000 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today.

Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com.

Basis of Consolidation

In accordance with generally accepted accounting principles in the United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation.

Forward Looking Statements

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties, such as:

● Regulatory and compliance risk, including state dental corporate practice of dentistry and fee-splitting restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare and labor regulations;

● Reimbursement risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity, enrollment and collections timing, and dependence on significant third-party payors;

● Our ability to identify, acquire, integrate and effectively support affiliated practices and to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions;

● Dependence on affiliated dental practices and their clinical performance; our ability to attract, hire and retain dentists, specialists and hygienists; and risks related to ownership transitions of affiliated entities;

● Competition for patients and clinicians in our markets and the impact on patient volumes and staffing;

● Macroeconomic conditions, inflation and interest rates, and our geographic concentration, particularly in the markets in which we operate.

A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise.

Non-GAAP Financial Measures

This news release and the related conference call include presentation of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends and to gain an understanding of the comparative operating performance of the Company.

Please note that the Company has not provided the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal settlements or other matters; and certain tax positions. The variability of these items could have an unpredictable, and potentially significant, impact on our future GAAP financial results.

See Supplemental non-GAAP financial tables below for a reconciliation of adjusted non-GAAP financial measures to GAAP.

Company Contact Information

Investor Contact:

Park Dental Partners Investor Relations Team

763-233-3377

ir@parkdentalpartners.com

Media Contact:

Park Dental Partners Media Relations Team

651-633-0500

marketing@parkdentalpartners.com

Supplemental Financial Tables

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

(in thousands, except share and per share amounts)

Three Months Ended

Six Months Ended

June 30,

2026

2025

2026

2025

REVENUE

66,212

62,998

128,907

122,035

COST OF SERVICES

Salaries and benefits

42,114

37,096

84,009

72,733

Dental supplies and Laboratory fees

4,444

4,337

8,782

8,576

Office occupancy

4,375

4,086

8,660

8,090

Other practice expenses

3,836

3,610

7,670

7,015

Depreciation

1,928

1,963

3,891

3,859

TOTAL COST OF SERVICES

56,698

51,092

113,013

100,273

GROSS MARGIN

9,514

11,906

15,894

21,762

General and administrative expenses

7,836

7,380

15,676

14,308

Depreciation and amortization

422

374

842

752

OPERATING INCOME (LOSS)

1,256

4,152

(624)

6,702

INTEREST EXPENSE - NET

(137)

(334)

(258)

(671)

INCOME (LOSS) BEFORE TAX

1,119

3,818

(882)

6,031

PROVISION/(BENEFIT) FOR INCOME TAX

(230)

1,248

(1,841)

1,894

NET INCOME

1,349

2,570

959

4,136

Earnings per share:

Basic

0.30

1.45

0.21

2.33

Diluted

0.22

1.45

0.16

2.33

Basic weighted-average number of common shares outstanding

4,571,346

1,772,662

4,478,159

1,777,942

Diluted weighted-average number of common shares outstanding

6,235,305

1,772,662

6,091,899

1,777,942

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEET (unaudited)

(in thousands)

At June 30,

At December 31,

2026

2025

ASSETS

Cash and cash equivalents

24,398

25,185

Accounts receivable – net of allowance

7,923

6,991

Other current assets

7,328

5,726

Total current assets

39,649

37,902

OTHER ASSETS:

Property and equipment and lease assets

75,286

73,828

Goodwill and Intangible assets, nets

30,591

28,360

Other assets

40,741

38,093

Total other assets

146,618

140,281

TOTAL ASSETS

186,267

178,183

LIABILITIES AND DEFICIT

Accounts payable and other accrued liabilities

5,041

6,291

Payroll, benefits and short term deferred compensation

16,693

16,716

Current portion of debt and lease liabilities

8,843

8,606

Deferred Revenue and other current liabilities

4,724

4,120

Total current liabilities

35,301

35,733

LONG-TERM LIABILITIES:

Deferred compensation

69,230

68,417

Long-term debt and lease liabilities

51,256

51,744

Other long-term liabilities

659

486

Total long-term liabilities

121,145

120,647

TOTAL LIABILITIES

156,446

156,380

Total shareholders’ equity

29,821

21,803

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

186,267

178,183

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

(in thousands)

Six Months Ended

June 30,

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income

959

4,136

Adjustments to reconcile net income to net cash flows from operating activities:

Depreciation and amortization

4,733

4,611

Deferred income taxes

(967)

—

Change in cash surrender value of life insurance

(1,274)

(786)

Noncash lease and loss on disposal of equipment

Share based compensation

7,059

—

Changes in operating assets and liabilities

(825)

1,271

Net cash flows from operating activities

9,716

9,233

NET CASH FLOWS USED IN INVESTING ACTIVITIES:

Purchases of property and equipment

(4,752)

(4,020)

Life insurance premiums paid

(407)

(978)

Payments for purchases of dental practices

(2,438)

(803)

Issuance of notes to related parties

(600)

—

Net cash flows used in investing activities

(8,197)

(5,801)

CASH FLOWS USED IN FINANCING ACTIVITIES:

Dental practice purchase payments on deferred notes

(134)

(333)

Net change in checks issued in excess of cash balances

(1,201)

(1,504)

Net payments on debt and capital leases

(971)

(979)

Cash paid for Share Repurchase

—

(396)

Net cash flows used in financing activities

(2,306)

(3,212)

NET CHANGE IN CASH AND CASH EQUIVALENTS

(787)

220

CASH AND CASH EQUIVALENTS – Beginning of period

25,185

2,672

CASH AND CASH EQUIVALENTS - End of period

24,398

2,892

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

RECONCILIATION OF GROSS MARGIN TO ADJUSTED GROSS MARGIN (unaudited)

(in thousands)

For the three months ended

For the six months ended

June 30,

2026

2025

2026

2025

Gross Margin

9,514

14.4%

11,906

18.9%

15,894

12.3%

21,762

17.8%

Addback:

Share based compensation

2,798

4.2%

0.0%

6,463

5.0%

0.0%

Restructuring costs

0.0%

0.1%

0.0%

109

0.1%

Deferred compensation

433

0.7%

170

0.3%

593

0.5%

255

0.2%

Depreciation

1,928

2.9%

1,963

3.1%

3,891

3.0%

3,859

3.2%

Adjusted Gross Margin

14,673

14,085

26,878

25,985

Adjusted Gross Margin Percentage

22.2%

22.4%

20.9%

21.3%

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (unaudited)

(in thousands)

For the three months ended

For the six months ended

June 30,

2026

2025

2026

2025

Net income attributable to Park Dental Partners, Inc.

1,349

2.0%

2,570

4.1%

959

0.7%

4,136

3.4%

Addback/(Deduct):

Provision/(Benefit) for income taxes

(230)

(0.3%)

1,248

2.0%

(1,841)

(1.4%)

1,894

1.6%

Interest expense, net

137

0.2%

334

0.5%

258

0.2%

671

0.5%

Depreciation and amortization

2,350

3.5%

2,337

3.7%

4,733

3.7%

4,611

3.8%

EBITDA

3,606

5.4%

6,489

10.3%

4,109

3.2%

11,312

9.3%

Adjustments:

Share based compensation

3,035

4.6%

0.0%

7,059

5.5%

0.0%

Restructuring costs(1)

347

0.5%

893

1.4%

405

0.3%

1,376

1.1%

Deferred compensation(2)

433

0.7%

170

0.3%

593

0.5%

329

0.3%

Adjusted EBITDA

7,421

7,552

12,166

13,017

Adjusted EBITDA Percentage

11.2%

12.0%

9.4%

10.7%

(1) Restructuring costs for the three and six months ended June 30, 2026 primarily consist of expenses related to acquisition legal costs. Restructuring costs for the three and six months ended June 30, 2025 primarily consist of expenses incurred in connection with the Company’s initial public offering.

(2) Deferred compensation costs primarily consist of expenses incurred with the Company's active and inactive deferred compensation arrangements.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

RECONCILIATION OF EARNINGS PER SHARE TO ADJUSTED EARNINGS PER SHARE (unaudited)

(in thousands, except share and per share amounts)

For the three months ended

For the six months ended

June 30,

2026

2025

2026

2025

EARNINGS ATTRIBUTABLE TO COMMON SHAREHOLDERS:

1,349

2,570

959

4,136

Adjustments:

Share based compensation

3,035

7,059

Restructuring costs(1)

347

893

405

1,376

Deferred compensation(2)

433

170

593

329

Income tax effect of the Adjustments(3)

(1,068)

(297)

(2,256)

(477)

ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS

4,096

3,336

6,760

5,364

Adjusted Weighted Average Diluted Shares - Reconciliation

WEIGHTED-AVERAGE SHARES USED IN COMPUTING GAAP NET EARNINGS PER SHARE, DILUTED

6,235,305

1,772,662

6,091,899

1,777,942

ADJUSTED WEIGHTED AVERAGE DILUTED SHARES USED IN COMPUTING ADJUSTED EARNINGS PER SHARE, DILUTED

6,235,305

1,772,662

6,091,899

1,777,942

ADJUSTED DILUTED EARNINGS PER SHARE:

0.66

1.88

1.11

3.02

(2) Deferred compensation costs primarily consist of expenses incurred with the Company's active and inactive deferred compensation arrangements.

(3) Income tax effect is based on an estimated long-term annual effective tax rate of 28% tax rate for the three and six months ended June 30, 2026 and June 30, 2025. The Company's estimated long-term annual effective tax rate excludes certain non-cash items such as share based compensation arrangements, and is used in order to provide consistency across periods.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONSOLIDATED OPERATING METRICS (unaudited)

Three Months Ended

Six Months Ended

June 30,

2026

2025

2026

2025

Patient Visits(1)

185,569

185,189

364,096

361,129

Same Practice Revenue Growth(2)

2.3%

5.8%

3.2%

3.6%

Patient Retention Rate(3)

90.3%

89.7%

90.3%

89.7%

Doctor Count(4)

219

203

(1) A patient visit is counted when service is provided to a patient at one of our affiliated dental general dentistry practices. Measuring the year-over-year change in patient visits helps us to evaluate how the affiliated dental practices are performing. It also helps with evaluating demand for services which influences decision-making relating to matters such as appropriate staffing levels and recruiting needs. In addition, it influences decision-making processes relating to our marketing, sales and advertising strategies and helps us with evaluating the effectiveness of those strategies. Further, with respect to continuing care patient count, it allows us to evaluate the ability of affiliated dentists to encourage patients to complete their diagnosed dental treatment plans.

(2) Same practice revenues represent total revenues for same dental practice locations that have been operating for at least 13 full months prior to the end of a given reporting period and which have not been closed, or sold during such period. Measuring the year-over-year change in same practice revenues allows us to evaluate how affiliated dental practices are performing. We believe various factors affect comparable practice revenues, including patient demand for dental services, economic trends, dentist and hygienist staffing levels, availability of dentists and hygienists, pricing, competition, visibility and accessibility of the dental practices, quality of the tenants surrounding the dental practices, clinical hours and the level of patient service provided inside and outside of the dental practices.

(3) Patient retention rate is calculated by counting patients that remain active at the beginning and end of a twelve-month period. Active patients are defined as general dentistry patients having been seen by our affiliated dental practices within the past 36 months, or last 18 months for patients under the age of 18. Patients who have not been seen by our affiliated dental practices within these time periods are removed from our active patient lists. This methodology is aligned with ADA clinical procedure codes, and is consistent with treatment protocols for new patients, before being considered an active patient again. Measuring the year-over-year and quarter-over-quarter change in patient retention allows us to evaluate the recurring nature of patient visits at the dental practices and affiliated dentists which influences decision-making around matters such as appropriate levels of staffing, recruiting, advertising and facility expansion opportunities.

(4) Dentists operating in one of our affiliated dental practices are included in this calculation, which includes both full and part-time dentists. Measuring the year-over-year and quarter-over- quarter change in dentist count allows us to evaluate the production capacity of affiliated dental practices. It also influences decision-making relating to matters such as appropriate staffing levels and recruiting needs.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Document and Entity Information

Aug. 12, 2026

Document and Entity Information [Abstract]

Document Type

8-K

Document Period End Date

Aug. 12, 2026

Entity File Number

001-42967

Entity Registrant Name

Park Dental Partners, Inc.

Entity Incorporation, State or Country Code

Entity Tax Identification Number

93-2020683

Entity Address State Or Province

Entity Address, Address Line One

2200 County Road C West

Entity Address, Adress Line Two

Suite 2210

Entity Address, City or Town

Roseville

Entity Address, Postal Zip Code

55113

City Area Code

651

Local Phone Number

633-0500

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.0001 per share

Trading Symbol

PARK

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Entity Ex Transition Period

true

Entity Central Index Key

0002069604

Amendment Flag

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration